Cargando…

Transcriptome profile and clinical characterization of ICOS expression in gliomas

Inducible co-stimulator (ICOS), an immune costimulatory molecule, has been found to play an essential role across various malignancies. This study investigated the transcriptome profile and clinical characterization of ICOS in gliomas. Clinical information and transcriptome data of 301 glioma sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin, Shi, Fei, Shan, Aijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582985/ https://www.ncbi.nlm.nih.gov/pubmed/36276141 http://dx.doi.org/10.3389/fonc.2022.946967

Ejemplares similares

Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response
por: Wang, Jin, et al.
Publicado: (2023)

Molecular and Clinical Characterization of LIGHT/TNFSF14 Expression at Transcriptional Level via 998 Samples With Brain Glioma
por: Yang, Ying, et al.
Publicado: (2021)

Pathological Grade-Associated Transcriptome Profiling of lncRNAs and mRNAs in Gliomas
por: Sun, Junlong, et al.
Publicado: (2020)

Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2021)

Correlation Between APOBEC3B Expression and Clinical Characterization in Lower-Grade Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype
por: Moreno-Cortes, Eider, et al.
Publicado: (2023)

The clinical impact of ICOS signal in colorectal cancer patients
por: Zhang, Yan, et al.
Publicado: (2016)

Transcriptome Sequencing Reveals Potential Roles of ICOS in Primary Sjögren’s Syndrome
por: Luo, Jing, et al.
Publicado: (2020)

S-nitrosoglutathione modulates CXCR4 and ICOS expression
por: Yamamoto, Yoshihiko, et al.
Publicado: (2006)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
por: Li, Hainan, et al.
Publicado: (2021)

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
por: Shen, Chan-Juan, et al.
Publicado: (2013)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

Differential Expression Profile of lncRNA in Glioma Cells and the Effect of lncRNA NKX3-1 on Glioma Cells Through Fem1b/SPDEF Pathway
por: Cai, Yang, et al.
Publicado: (2021)

ICOS Gene Polymorphisms (IVS1 + 173 T/C and c. 1624 C/T) in Primary Sjögren’s Syndrome Patients: Analysis of ICOS Expression
por: García-Espinoza, José Antonio, et al.
Publicado: (2022)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
por: Brągiel-Pieczonka, Aneta, et al.
Publicado: (2022)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
por: Ralser, Damian J., et al.
Publicado: (2023)

Regulation of T follicular helper cells by ICOS
por: Hutloff, Andreas
Publicado: (2015)

ICOS regulates ILC2s in asthma
por: Maazi, Hadi, et al.
Publicado: (2015)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
por: Wu, Shan, et al.
Publicado: (2020)

Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency
por: Abolhassani, Hassan, et al.
Publicado: (2019)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

Prognostic and Clinic Pathological Value of Cx43 Expression in Glioma: A Meta-Analysis
por: Zhang, Chao, et al.
Publicado: (2019)

Integrated Analysis of the Clinical and Molecular Characteristics of IDH Wild-Type Gliomas in the Chinese Glioma Genome Atlas
por: Wang, Peng, et al.
Publicado: (2021)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
por: Ji, Xiaoshuai, et al.
Publicado: (2020)

Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling
por: Wang, Jin, et al.
Publicado: (2022)

Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder
por: Xue, Qun, et al.
Publicado: (2019)

Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism
por: Li, Ping, et al.
Publicado: (2022)

IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

Interactions between microglia and glioma in tumor microenvironment
por: Tao, Jin-Cheng, et al.
Publicado: (2023)

Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment
por: Liu, Kristie, et al.
Publicado: (2020)

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas
por: Ba, Yueyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9ch22rp3r9dp52i8bp06nj6qm